Myelodysplastic syndromes (MDS) are malignant hematopoietic stem cell disorders that occur primarily in the older adult population and have a yearly incidence of 30 in 100,000 in persons 70 years and older. The eventual clinical outcome for patients with MDS relates to either bone marrow failure or leukemic transformations.
The post A Guide to Diagnosis and Follow-up of Myelodysplastic Syndrome [Utilization Spotlight] appeared first on Insights.